» Articles » PMID: 21712519

The Risk of Incident Coronary Heart Disease Among Veterans with and Without HIV and Hepatitis C

Abstract

Background: Whether hepatitis C virus (HCV) confers additional coronary heart disease (CHD) risk among human immunodeficiency virus (HIV) infected individuals is unclear. Without appropriate adjustment for antiretroviral therapy, CD4 count, and HIV-1 RNA and substantially different mortality rates among those with and without HIV and HCV infection, the association between HIV, HCV, and CHD may be obscured.

Methods And Results: We analyzed data on 8579 participants (28% HIV+, 9% HIV+HCV+) from the Veterans Aging Cohort Study Virtual Cohort who participated in the 1999 Large Health Study of Veteran Enrollees. We analyzed data collected on HIV and HCV status, risk factors for and the incidence of CHD, and mortality from January 2000 to July 2007. We compared models to assess CHD risk when death was treated as a censoring event and as a competing risk. During the median 7.3 years of follow-up, there were 194 CHD events and 1186 deaths. Compared with HIV-HCV- Veterans, HIV+HCV+ Veterans had a significantly higher risk of CHD regardless of whether death was adjusted for as a censoring event (adjusted hazard ratio, 2.03; 95% confidence interval, 1.28 to 3.21) or a competing risk (adjusted HR, 2.45; 95% confidence interval, 1.83 to 3.27 respectively). Compared with HIV+HCV- Veterans, HIV+HCV+ Veterans also had a significantly higher adjusted risk of CHD regardless of whether death was treated as a censored event (adjusted hazard ratio, 1.93; 95% confidence interval, 1.02 to 3.62) or a competing risk (adjusted hazard ratio, 1.46; 95% confidence interval, 1.03 to 2.07).

Conclusions: HIV+HCV+ Veterans have an increased risk of CHD compared with HIV+HCV- and HIV-HCV- Veterans.

Citing Articles

Changes in Atherosclerotic Cardiovascular Disease Risk Scores in a Predominantly Black Cohort with HIV and Associated Comorbidities: A Preliminary Study.

Burrowes S, Zisman E, Fantry L, Bui Q, Wu A, Sorkin J Cardiology. 2024; :1-9.

PMID: 39106839 PMC: 11799351. DOI: 10.1159/000540526.


Inflammatory and Immune Mechanisms for Atherosclerotic Cardiovascular Disease in HIV.

Hmiel L, Zhang S, Obare L, Santana M, Wanjalla C, Titanji B Int J Mol Sci. 2024; 25(13).

PMID: 39000373 PMC: 11242562. DOI: 10.3390/ijms25137266.


The Potential of Clostridium butyricum to Preserve Gut Health, and to Mitigate Non-AIDS Comorbidities in People Living with HIV.

Yang Q, Zaongo S, Zhu L, Yan J, Yang J, Ouyang J Probiotics Antimicrob Proteins. 2024; 16(4):1465-1482.

PMID: 38336953 DOI: 10.1007/s12602-024-10227-1.


The Association of Prescribed Opioids and Incident Cardiovascular Disease.

Sung M, Eden S, Becker W, Crystal S, Duncan M, Gordon K J Pain. 2023; 25(5):104436.

PMID: 38029949 PMC: 11058015. DOI: 10.1016/j.jpain.2023.11.019.


Proprotein convertase subtisilin/kexin 9 levels decline with hepatitis C virus therapy in people with HIV/hepatitis C virus and correlate with inflammation.

Gandhi M, Nguyen K, Lake J, Liao D, Khodabakhshian A, Guerrero M AIDS. 2023; 38(3):317-327.

PMID: 37788081 PMC: 10841736. DOI: 10.1097/QAD.0000000000003739.


References
1.
Brenchley J, Price D, Schacker T, Asher T, Silvestri G, Rao S . Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006; 12(12):1365-71. DOI: 10.1038/nm1511. View

2.
Tomiyama H, Arai T, Hirose K, Hori S, Yamamoto Y, Yamashina A . Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity. Atherosclerosis. 2003; 166(2):401-3. DOI: 10.1016/s0021-9150(02)00388-x. View

3.
Mehta S, Brancati F, Sulkowski M, Strathdee S, Szklo M, Thomas D . Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med. 2000; 133(8):592-9. DOI: 10.7326/0003-4819-133-8-200010170-00009. View

4.
Volzke H, Schwahn C, Wolff B, Mentel R, Robinson D, Kleine V . Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis. 2004; 174(1):99-103. DOI: 10.1016/j.atherosclerosis.2004.01.010. View

5.
Weber R, Sabin C, Friis-Moller N, Reiss P, El-Sadr W, Kirk O . Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006; 166(15):1632-41. DOI: 10.1001/archinte.166.15.1632. View